Zinc levels in maternal and cord blood and in amniotic fluid--a possible marker for foetal malformation.
Zinc levels were estimated from the maternal and cord blood drawn at delivery and in the amniotic fluid drawn before delivery in 9 pregnancies resulting in congenitally abnormal foetuses and 21 pregnancies resulting in normal healthy babies. Zinc levels were significantly lower (P < 0.01) in maternal and cord blood serum in congenitally malformed babies as compared to healthy normal controls. Amniotic fluid zinc levels were significantly higher (P < 0.01) in pregnancies with malformed babies. The use of zinc levels as marker for foetal malformation has been suggested.
Sharma
R
R
Department of Obstetrics & Gynaecology, J.N. Medical College, A.M.U., Aligarh.
Tewari
K
K
Singhal
K C
KC
Gupta
M
M
Veena
D000653:Amniotic Fluid / Q000737:chemistry*; D015415:Biomarkers / Q000097:blood; D000013:Congenital Abnormalities / Q000175:diagnosis*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy / Q000097:blood*; D011296:Prenatal Diagnosis; D015032:Zinc / Q000097:blood*
D015415:Biomarkers; D015032:Zinc